{"title":"需要前瞻性研究来评估神经新冠病毒的患病率/发病率","authors":"J. Finsterer, F. Scorza","doi":"10.47363/jmhc/2021(3)153","DOIUrl":null,"url":null,"abstract":"Letter to the Editor With interest we read the article by Khedr et al. about a retrospective cohort study of 117 patients with neuro-COVID collected during a three months period in Upper Egypt [1]. It was found that stroke was the most frequent central nervous system (CNS) manifestation of neuro-COVID in this cohort and that anosmia/ageusia was the most frequent peripheral nervous system (PNS) manifestation of neuro-COVID [1]. The study is appealing but raises the following comments and concerns.","PeriodicalId":93468,"journal":{"name":"Journal of medicine and healthcare","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2020-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Prospective Studies are Required to Assess the Prevalence/Incidence of Neuro-Covid\",\"authors\":\"J. Finsterer, F. Scorza\",\"doi\":\"10.47363/jmhc/2021(3)153\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Letter to the Editor With interest we read the article by Khedr et al. about a retrospective cohort study of 117 patients with neuro-COVID collected during a three months period in Upper Egypt [1]. It was found that stroke was the most frequent central nervous system (CNS) manifestation of neuro-COVID in this cohort and that anosmia/ageusia was the most frequent peripheral nervous system (PNS) manifestation of neuro-COVID [1]. The study is appealing but raises the following comments and concerns.\",\"PeriodicalId\":93468,\"journal\":{\"name\":\"Journal of medicine and healthcare\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-06-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of medicine and healthcare\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.47363/jmhc/2021(3)153\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of medicine and healthcare","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.47363/jmhc/2021(3)153","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Prospective Studies are Required to Assess the Prevalence/Incidence of Neuro-Covid
Letter to the Editor With interest we read the article by Khedr et al. about a retrospective cohort study of 117 patients with neuro-COVID collected during a three months period in Upper Egypt [1]. It was found that stroke was the most frequent central nervous system (CNS) manifestation of neuro-COVID in this cohort and that anosmia/ageusia was the most frequent peripheral nervous system (PNS) manifestation of neuro-COVID [1]. The study is appealing but raises the following comments and concerns.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
